NCT06252961View on ClinicalTrials.gov

A 3- to 5-day Clinical Trial of Levamisole in Loiasis Infected Subjects

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

June 21, 2024

Primary Completion Date

September 18, 2024

Study Completion Date

February 1, 2026

Conditions
Loiasis
Interventions
DRUG

Levamisole 3 days

Levamisole for 3 days (2,5 mg/kg) then placebo for 2 days

DRUG

Levamisole 5 days

Levamisole for 5 days (2,5 mg/kg)

DRUG

Placebo

Placebo for 5 days

Trial Locations (2)

Unknown

RECRUITING

Supervisor, Sibiti

RECRUITING

General Supervisor, Sibiti

All Listed Sponsors
collaborator

Institut de Recherche pour le Developpement

OTHER_GOV

lead

Programme National de Lutte contre l'Onchocercose, Republic of the Congo

OTHER_GOV